- Home
- LSTR vs VKTX Comparison
LSTR vs VKTX Comparison
Compare LSTR & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSTR | VKTX |
|---|---|---|
| Founded | 1991 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.8B |
| IPO Year | 1993 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LSTR | VKTX |
|---|---|---|
| Price | $143.53 | $35.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $137.45 | $87.07 |
| AVG Volume (30 Days) | 425.9K | ★ 2.8M |
| Earning Date | 01-28-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.49% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.92 | N/A |
| Revenue | ★ $4,793,063,000.00 | N/A |
| Revenue This Year | $0.52 | N/A |
| Revenue Next Year | $5.25 | N/A |
| P/E Ratio | $36.86 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $119.32 | $18.92 |
| 52 Week High | $186.76 | $48.55 |
Technical Indicators
Market Signals| Indicator | LSTR | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 62.90 | 45.46 |
| Support Level | $130.07 | $35.00 |
| Resistance Level | $152.50 | $38.50 |
| Average True Range (ATR) | 4.43 | 1.80 |
| MACD | 0.54 | -0.23 |
| Stochastic Oscillator | 61.47 | 24.76 |
Price Performance
Historical ComparisonAbout LSTR Landstar System Inc.
Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.